The large trial recruited patients with 2 or more recurrent bouts of leg cellulitis and randomized them to 12 months of penicillin (250mg BID) or placebo. Recurrence was lower in the penicillin group (22% vs 37%), with no difference in adverse effects (abstract).
Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.